156 related articles for article (PubMed ID: 21701578)
1. Chemical linkage to injected tissues is a distinctive property of oxidized avidin.
De Santis R; Anastasi AM; Pelliccia A; Rosi A; Albertoni C; Verdoliva A; Petronzelli F; D'Alessio V; Serani S; Nuzzolo CA
PLoS One; 2011; 6(6):e21075. PubMed ID: 21701578
[TBL] [Abstract][Full Text] [Related]
2. Characterization of therapeutic protein AvidinOX by an integrated analytical approach.
Giannini G; Alekseeva A; Naggi A; Salvini L; Tei L; De Santis R
Anal Bioanal Chem; 2018 Jan; 410(2):553-564. PubMed ID: 29167933
[TBL] [Abstract][Full Text] [Related]
3. AvidinOX™ for tissue targeted delivery of biotinylated cells.
Nucera E; Nicoletti C; Chiapparino C; Pacello ML; D'Alessio V; Musarò A; De Santis R
Int J Immunopathol Pharmacol; 2012; 25(1):239-46. PubMed ID: 22507336
[TBL] [Abstract][Full Text] [Related]
4. Preclinical pharmacology and safety of a novel avidin derivative for tissue-targeted delivery of radiolabelled biotin.
Petronzelli F; Anastasi AM; Pelliccia A; Santapaola D; Albertoni C; Rosi A; Leoni B; Ferrari LE; Paganelli G; Gramiccioli G; Pesce D; Alfano AM; Stasi MA; De Santis R
Basic Clin Pharmacol Toxicol; 2011 Sep; 109(3):145-55. PubMed ID: 21426491
[TBL] [Abstract][Full Text] [Related]
5. AvidinOX for highly efficient tissue-pretargeted radionuclide therapy.
De Santis R; Leoni B; Rosi A; Albertoni C; Forni G; Cojoca R; Iezzi M; Musiani P; Paganelli G; Chinol M; Carminati P
Cancer Biother Radiopharm; 2010 Apr; 25(2):143-8. PubMed ID: 20423226
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and biological characterization of a new oxidized avidin with enhanced tissue binding properties.
Verdoliva A; Bellofiore P; Rivieccio V; Catello S; Colombo M; Albertoni C; Rosi A; Leoni B; Anastasi AM; De Santis R
J Biol Chem; 2010 Mar; 285(12):9090-9. PubMed ID: 20100839
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibition of human ovarian carcinoma by a novel AvidinOX-anchored biotinylated camptothecin derivative.
Minenkova O; Vesci L; De Santis R; Santapaola D; Cincinelli R; Musso L; Dallavalle S; Giannini G
Bioorg Med Chem Lett; 2018 Nov; 28(20):3312-3314. PubMed ID: 30243588
[TBL] [Abstract][Full Text] [Related]
8. Chicken avidin-related proteins show altered biotin-binding and physico-chemical properties as compared with avidin.
Laitinen OH; Hytönen VP; Ahlroth MK; Pentikäinen OT; Gallagher C; Nordlund HR; Ovod V; Marttila AT; Porkka E; Heino S; Johnson MS; Airenne KJ; Kulomaa MS
Biochem J; 2002 May; 363(Pt 3):609-17. PubMed ID: 11964162
[TBL] [Abstract][Full Text] [Related]
9. OXavidin for tissue targeting biotinylated therapeutics.
De Santis R; Albertoni C; Rosi A; Leoni B; Petronzelli F; D'Alessio V; Nucera E; Salvatori G; Paganelli G; Verdoliva A; Carminati P; Nuzzolo CA
J Biomed Biotechnol; 2009; 2009():921434. PubMed ID: 20130784
[TBL] [Abstract][Full Text] [Related]
10. Tissue distribution of avidin and streptavidin injected to mice. Effect of avidin carbohydrate, streptavidin truncation and exogenous biotin.
Schechter B; Silberman R; Arnon R; Wilchek M
Eur J Biochem; 1990 Apr; 189(2):327-31. PubMed ID: 2186907
[TBL] [Abstract][Full Text] [Related]
11. Radionuclide Therapy of Unresectable Tumors with AvidinOX and (90)Y-biotinDOTA: Tongue Cancer Paradigm.
Albertoni C; Leoni B; Rosi A; D'Alessio V; Carollo V; Spagnoli LG; van Echteld C; De Santis R
Cancer Biother Radiopharm; 2015 Sep; 30(7):291-8. PubMed ID: 26167947
[TBL] [Abstract][Full Text] [Related]
12. AvidinOX-anchored biotinylated trastuzumab and pertuzumab induce down-modulation of ErbB2 and tumor cell death at concentrations order of magnitude lower than not-anchored antibodies.
Milazzo FM; Anastasi AM; Chiapparino C; Rosi A; Leoni B; Vesci L; Petronzelli F; De Santis R
Oncotarget; 2017 Apr; 8(14):22590-22605. PubMed ID: 28186982
[TBL] [Abstract][Full Text] [Related]
13. Interference of sugars with the binding of biotin to streptavidin and avidin.
Houen G; Hansen K
J Immunol Methods; 1997 Dec; 210(2):115-23. PubMed ID: 9520295
[TBL] [Abstract][Full Text] [Related]
14. EGF receptor targeted tumor imaging with biotin-PEG-EGF linked to (99m)Tc-HYNIC labeled avidin and streptavidin.
Jung KH; Park JW; Paik JY; Quach CH; Choe YS; Lee KH
Nucl Med Biol; 2012 Nov; 39(8):1122-7. PubMed ID: 22819251
[TBL] [Abstract][Full Text] [Related]
15. Dimer-tetramer transition between solution and crystalline states of streptavidin and avidin mutants.
Pazy Y; Eisenberg-Domovich Y; Laitinen OH; Kulomaa MS; Bayer EA; Wilchek M; Livnah O
J Bacteriol; 2003 Jul; 185(14):4050-6. PubMed ID: 12837778
[TBL] [Abstract][Full Text] [Related]
16. Switchavidin: reversible biotin-avidin-biotin bridges with high affinity and specificity.
Taskinen B; Zauner D; Lehtonen SI; Koskinen M; Thomson C; Kähkönen N; Kukkurainen S; Määttä JA; Ihalainen TO; Kulomaa MS; Gruber HJ; Hytönen VP
Bioconjug Chem; 2014 Dec; 25(12):2233-43. PubMed ID: 25405260
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional structures of avidin and the avidin-biotin complex.
Livnah O; Bayer EA; Wilchek M; Sussman JL
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5076-80. PubMed ID: 8506353
[TBL] [Abstract][Full Text] [Related]
18. Avidin targeting of intraperitoneal tumor xenografts.
Yao Z; Zhang M; Sakahara H; Saga T; Arano Y; Konishi J
J Natl Cancer Inst; 1998 Jan; 90(1):25-9. PubMed ID: 9428779
[TBL] [Abstract][Full Text] [Related]
19. The use of avidin-biotinylglycan as the model for in vitro glycoprotein processing.
Shao MC; Wold F
J Biol Chem; 1987 Mar; 262(7):2968-72. PubMed ID: 3102481
[TBL] [Abstract][Full Text] [Related]
20. (Strept)avidin-displaying lentiviruses as versatile tools for targeting and dual imaging of gene delivery.
Kaikkonen MU; Lesch HP; Pikkarainen J; Räty JK; Vuorio T; Huhtala T; Taavitsainen M; Laitinen T; Tuunanen P; Gröhn O; Närvänen A; Airenne KJ; Ylä-Herttuala S
Gene Ther; 2009 Jul; 16(7):894-904. PubMed ID: 19440224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
